151 related articles for article (PubMed ID: 27211987)
1. α-Synuclein induced toxicity in brain stem serotonin neurons mediated by an AAV vector driven by the tryptophan hydroxylase promoter.
Wan OW; Shin E; Mattsson B; Caudal D; Svenningsson P; Björklund A
Sci Rep; 2016 May; 6():26285. PubMed ID: 27211987
[TBL] [Abstract][Full Text] [Related]
2. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A
Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688
[TBL] [Abstract][Full Text] [Related]
3. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons.
Caudal D; Alvarsson A; Björklund A; Svenningsson P
Exp Neurol; 2015 Nov; 273():243-52. PubMed ID: 26363495
[TBL] [Abstract][Full Text] [Related]
4. Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons.
Aldrin-Kirk P; Davidsson M; Holmqvist S; Li JY; Björklund T
PLoS One; 2014; 9(7):e100869. PubMed ID: 24999658
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
Deusser J; Schmidt S; Ettle B; Plötz S; Huber S; Müller CP; Masliah E; Winkler J; Kohl Z
J Neurochem; 2015 Nov; 135(3):589-97. PubMed ID: 26201615
[TBL] [Abstract][Full Text] [Related]
6. Prenatal stress and subsequent exposure to chronic mild stress in rats; interdependent effects on emotional behavior and the serotonergic system.
Van den Hove DL; Leibold NK; Strackx E; Martinez-Claros M; Lesch KP; Steinbusch HW; Schruers KR; Prickaerts J
Eur Neuropsychopharmacol; 2014 Apr; 24(4):595-607. PubMed ID: 24139910
[TBL] [Abstract][Full Text] [Related]
7. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.
Kohl Z; Ben Abdallah N; Vogelgsang J; Tischer L; Deusser J; Amato D; Anderson S; Müller CP; Riess O; Masliah E; Nuber S; Winkler J
Neurobiol Dis; 2016 Jan; 85():206-217. PubMed ID: 26523794
[TBL] [Abstract][Full Text] [Related]
8. Medullary neuronal loss is not associated with α-synuclein burden in multiple system atrophy.
Coon EA; Schmeichel AM; Parisi JE; Cykowski MD; Low PA; Benarroch EE
Mov Disord; 2016 Dec; 31(12):1802-1809. PubMed ID: 27629118
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of neonatal hypoxic-ischemic brain injury on brainstem serotonergic raphe nuclei.
Reinebrant HE; Wixey JA; Gobe GC; Colditz PB; Buller KM
Brain Res; 2010 Mar; 1322():124-33. PubMed ID: 20122905
[TBL] [Abstract][Full Text] [Related]
10. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
11. Emotional memory impairments induced by AAV-mediated overexpression of human α-synuclein in dopaminergic neurons of the ventral tegmental area.
Alvarsson A; Caudal D; Björklund A; Svenningsson P
Behav Brain Res; 2016 Jan; 296():129-133. PubMed ID: 26341317
[TBL] [Abstract][Full Text] [Related]
12. Layer-specific axonal degeneration of serotonergic fibers in the prefrontal cortex of aged A53T α-synuclein-expressing mice.
Wihan J; Grosch J; Kalinichenko LS; Müller CP; Winkler J; Kohl Z
Neurobiol Aging; 2019 Aug; 80():29-37. PubMed ID: 31077958
[TBL] [Abstract][Full Text] [Related]
13. Caudo-rostral brain spreading of α-synuclein through vagal connections.
Ulusoy A; Rusconi R; Pérez-Revuelta BI; Musgrove RE; Helwig M; Winzen-Reichert B; Di Monte DA
EMBO Mol Med; 2013 Jul; 5(7):1119-27. PubMed ID: 23703938
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.
Decressac M; Mattsson B; Björklund A
Exp Neurol; 2012 May; 235(1):306-15. PubMed ID: 22394547
[TBL] [Abstract][Full Text] [Related]
15. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
Maingay M; Romero-Ramos M; Carta M; Kirik D
Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
[TBL] [Abstract][Full Text] [Related]
16. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.
Rocha EM; Smith GA; Park E; Cao H; Brown E; Hayes MA; Beagan J; McLean JR; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
Neurobiol Dis; 2015 Oct; 82():495-503. PubMed ID: 26392287
[TBL] [Abstract][Full Text] [Related]
17. Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.
Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
Neuroscience; 2012 Feb; 203():170-9. PubMed ID: 22198020
[TBL] [Abstract][Full Text] [Related]
18. Origin of the serotonergic innervation to the rat dorsolateral hypothalamus: retrograde transport of cholera toxin and upregulation of tryptophan hydroxylase mRNA expression following selective nerve terminals lesion.
Ljubic-Thibal V; Morin A; Diksic M; Hamel E
Synapse; 1999 Jun; 32(3):177-86. PubMed ID: 10340628
[TBL] [Abstract][Full Text] [Related]
19. Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioral tests.
Gubinelli F; Cazzolla G; Negrini M; Kulacz I; Mehrdadian A; Tomasello G; Venuti C; Sarauskyte L; Jacobs F; Manfredsson FP; Davidsson M; Heuer A
Behav Brain Res; 2022 Jul; 429():113887. PubMed ID: 35405174
[TBL] [Abstract][Full Text] [Related]
20. Anxiogenic drug administration and elevated plus-maze exposure in rats activate populations of relaxin-3 neurons in the nucleus incertus and serotonergic neurons in the dorsal raphe nucleus.
Lawther AJ; Clissold ML; Ma S; Kent S; Lowry CA; Gundlach AL; Hale MW
Neuroscience; 2015 Sep; 303():270-84. PubMed ID: 26141847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
